RAPP
#2009
Rapport Therapeutics, Inc. - Common Stock
40.5 9 USD
-0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.78%
Variación mensual
+4.37%
Variación en los últimos 6 meses
+48.30%
Cambio anual
+54.98%
Cierres anteriores
41.7 5
Open
40.5 9
Mínimo
40.5 9
High
40.5 9
Volumen
46
Financials
- Market Capitalization 1.94 B
- Employee 84
- Founded 2022
- CEO N/A
- Website www.rapportrx.com
- Headquarter Delaware, United States
- FIGI BBG01FRNQ4P1
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1752 |  MBX MBX Biosciences, Inc. - Common Stock | 60.04 USD | -1.65% | +3.36% | +67.71% | +327.03% | 2.86 B USD | ||
| 1954 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 146.03 USD | +0.88% | +3.30% | +30.28% | +97.74% | 2.09 B USD | ||
| 2058 |  GENB Generate Biomedicines, Inc. - Common Stock | 14.28 USD | -0.35% | -15.65% | +12.89% | -4.80% | 1.83 B USD | ||
| 2140 |  MAZE Maze Therapeutics, Inc. - Common Stock | 29.18 USD | -4.55% | -10.22% | +19.93% | -35.20% | 1.61 B USD |